SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001493152-20-021951
Filing Date
2020-11-18
Accepted
2020-11-18 16:40:20
Documents
11

Document Format Files

Seq Description Document Type Size
1 form425.htm 425 10226
2 image_001.jpg GRAPHIC 57818
3 image_002.jpg GRAPHIC 295268
4 image_003.jpg GRAPHIC 104586
5 image_004.jpg GRAPHIC 79759
6 image_005.jpg GRAPHIC 97686
7 image_006.jpg GRAPHIC 133038
8 image_007.jpg GRAPHIC 97281
9 image_008.jpg GRAPHIC 101221
10 image_009.jpg GRAPHIC 85468
11 image_010.jpg GRAPHIC 44716
  Complete submission text file 0001493152-20-021951.txt   1523320
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filed by) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36268 | Film No.: 201325577
SIC: 2835 In Vitro & In Vivo Diagnostic Substances